BridgeMD
New treatment option for Upper Limb Amputation Above Elbow
Official title Long-Term Stability of the Glide Control Strategy
ClinicalTrials.gov ID: NCT07222085
What this study is testing
- What it's testing
- This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Unilateral trans-radial or trans-humeral limb loss with a healed residual limb
- Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist
- Age of 18 years or greater
You likely can't join if
- Prior experience with Pattern Recognition or Glide control
- Individuals with a residual limb that is unhealed from the amputation surgery
- Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes
- Significant cognitive deficits as determined upon clinical evaluation
- Significant neurological deficits as determined upon clinical evaluation
- Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
See the full eligibility criteria
- Unilateral trans-radial or trans-humeral limb loss with a healed residual limb
- Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist
- Age of 18 years or greater
- Prior experience with Pattern Recognition or Glide control
- Individuals with a residual limb that is unhealed from the amputation surgery
- Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes
- Significant cognitive deficits as determined upon clinical evaluation
- Significant neurological deficits as determined upon clinical evaluation
- Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
- Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
- Serious uncontrolled medical problems
The study team makes the final eligibility decision.
Where it's taking place
- Annapolis, Maryland, United States
- Baltimore, Maryland, United States
- Silver Spring, Maryland, United States
- Allston, Massachusetts, United States
- Milton, Massachusetts, United States
- Charlotte, North Carolina, United States
- Anderson, South Carolina, United States
- Greenville, South Carolina, United States
- Fairfax, Virginia, United States
- Leesburg, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Annapolis, Maryland, United States; Baltimore, Maryland, United States; Silver Spring, Maryland, United States; Allston, Massachusetts, United States; Milton, Massachusetts, United States; Charlotte, North Carolina, United States and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.